Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 9/20 | 0.58 |
| ▸ | SCN9A | Q15858 | 6/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4831416 | 0.92 | NR1I2 (0.60) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14253480 | 0.91 | NR1I2 (0.59) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14253463 | 0.88 | NR1I2 (0.56) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14253835 | 0.84 | NR1I2 (0.55) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14253196 | 0.83 | NR1I2 (0.62) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14435357 | 0.83 | SCN9A (0.54) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14253273 | 0.82 | NR1I2 (0.62) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14253464 | 0.81 | NR1I2 (0.60) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL5927398 | 0.81 | NR1I2 (0.60) | NR1I2SCN9ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14435351 | 0.80 | SCN9A (0.67) | NR1I2SCN9AKCNH2SCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007092000-A1 | INHIBITORS OF HCV REPLICATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-08-16 | — | — | WO | disclosed |